Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell CarcinomaMaria I. Carlo, Kenneth Offit, Carolyn Stewart et al.|JAMA Oncology|2018Cited by 202
Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non–Clear Cell Renal Cell CarcinomaMartin H. Voss, Darren R. Feldman, Ana M. Molina et al.|Journal of Clinical Oncology|2016Cited by 85
Genomic Characterization of Renal Medullary Carcinoma and Treatment OutcomesMaria I. Carlo, Chung‐Han Lee, Sujata Patil et al.|Clinical Genitourinary Cancer|2017Cited by 58
Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell CarcinomaMaria I. Carlo, Martin H. Voss, Brandon J. Manley et al.|Kidney Cancer|2017Cited by 49
Comprehensive Genomic Analysis of Metastatic Non–Clear-Cell Renal Cell Carcinoma to Identify Therapeutic TargetsMaria I. Carlo, Martin H. Voss, Nabeela Khan et al.|JCO Precision Oncology|2019Cited by 19